Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model

Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2008-09, Vol.72 (3), p.682-686
Hauptverfasser: Lake, Alison M, Hall, Timothy L, Kieran, Kathleen, Fowlkes, J. Brian, Cain, Charles A, Roberts, William W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 686
container_issue 3
container_start_page 682
container_title Urology (Ridgewood, N.J.)
container_volume 72
creator Lake, Alison M
Hall, Timothy L
Kieran, Kathleen
Fowlkes, J. Brian
Cain, Charles A
Roberts, William W
description Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.
doi_str_mv 10.1016/j.urology.2008.01.037
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69492788</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0090429508001064</els_id><sourcerecordid>69492788</sourcerecordid><originalsourceid>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</originalsourceid><addsrcrecordid>eNqFkkFv1DAQhS0EokvhJ4B8gVvC2EmcmAOoWgGt1AokFq6W40zAS9be2slK-fc4bAQSF06Wrfdm5n0eQp4zyBkw8XqfT8EP_vucc4AmB5ZDUT8gG1bxOpNSVg_JBkBCVnJZXZAnMe4BQAhRPyYXrCnSM2s2xFzbOPox2GOc39A76-xBD8NMb9xJR3tCukPzw_1uRHsf6Ofg46hHa-jOxjghvWqHdPWOWke1Sz76zZ483WpnHdI73-HwlDzq9RDx2Xpekq8f3u-219ntp48326vbzFSCjVnZ9r0xpQFuCp1CCeQgjCgYllXdM9b1HKq67bAUnRA9Vi2TTYFJI2XJmSwuyatz3WPw9xPGUR1sNDgM2qGfohKylLxumiSszkKT0sSAvTqGlDvMioFa6Kq9Wumqha4CphLd5HuxNpjaA3Z_XSvOJHi5CnQ0euiDdsbGP7qUpyp4vUz67qzDhONkMahoLDqDnQ1oRtV5-99R3v5TwQzp81LTnzhj3PspuMRaMRW5AvVlWYVlE6ABYCDK4he-n7Br</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69492788</pqid></control><display><type>article</type><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</creator><creatorcontrib>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</creatorcontrib><description>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</description><identifier>ISSN: 0090-4295</identifier><identifier>EISSN: 1527-9995</identifier><identifier>DOI: 10.1016/j.urology.2008.01.037</identifier><identifier>PMID: 18342918</identifier><identifier>CODEN: URGYAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Animals ; Biological and medical sciences ; Disease Models, Animal ; Dogs ; Equipment Design ; Humans ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Prostate - metabolism ; Prostate - pathology ; Prostatic Hyperplasia - diagnosis ; Prostatic Hyperplasia - therapy ; Subcellular Fractions ; Ultrasonic Therapy ; Ultrasound, High-Intensity Focused, Transrectal - instrumentation ; Ultrasound, High-Intensity Focused, Transrectal - methods ; Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.682-686</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</citedby><cites>FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0090429508001064$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20653279$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18342918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lake, Alison M</creatorcontrib><creatorcontrib>Hall, Timothy L</creatorcontrib><creatorcontrib>Kieran, Kathleen</creatorcontrib><creatorcontrib>Fowlkes, J. Brian</creatorcontrib><creatorcontrib>Cain, Charles A</creatorcontrib><creatorcontrib>Roberts, William W</creatorcontrib><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><title>Urology (Ridgewood, N.J.)</title><addtitle>Urology</addtitle><description>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</description><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Disease Models, Animal</subject><subject>Dogs</subject><subject>Equipment Design</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Prostate - metabolism</subject><subject>Prostate - pathology</subject><subject>Prostatic Hyperplasia - diagnosis</subject><subject>Prostatic Hyperplasia - therapy</subject><subject>Subcellular Fractions</subject><subject>Ultrasonic Therapy</subject><subject>Ultrasound, High-Intensity Focused, Transrectal - instrumentation</subject><subject>Ultrasound, High-Intensity Focused, Transrectal - methods</subject><subject>Urology</subject><issn>0090-4295</issn><issn>1527-9995</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkkFv1DAQhS0EokvhJ4B8gVvC2EmcmAOoWgGt1AokFq6W40zAS9be2slK-fc4bAQSF06Wrfdm5n0eQp4zyBkw8XqfT8EP_vucc4AmB5ZDUT8gG1bxOpNSVg_JBkBCVnJZXZAnMe4BQAhRPyYXrCnSM2s2xFzbOPox2GOc39A76-xBD8NMb9xJR3tCukPzw_1uRHsf6Ofg46hHa-jOxjghvWqHdPWOWke1Sz76zZ483WpnHdI73-HwlDzq9RDx2Xpekq8f3u-219ntp48326vbzFSCjVnZ9r0xpQFuCp1CCeQgjCgYllXdM9b1HKq67bAUnRA9Vi2TTYFJI2XJmSwuyatz3WPw9xPGUR1sNDgM2qGfohKylLxumiSszkKT0sSAvTqGlDvMioFa6Kq9Wumqha4CphLd5HuxNpjaA3Z_XSvOJHi5CnQ0euiDdsbGP7qUpyp4vUz67qzDhONkMahoLDqDnQ1oRtV5-99R3v5TwQzp81LTnzhj3PspuMRaMRW5AvVlWYVlE6ABYCDK4he-n7Br</recordid><startdate>20080901</startdate><enddate>20080901</enddate><creator>Lake, Alison M</creator><creator>Hall, Timothy L</creator><creator>Kieran, Kathleen</creator><creator>Fowlkes, J. Brian</creator><creator>Cain, Charles A</creator><creator>Roberts, William W</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20080901</creationdate><title>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</title><author>Lake, Alison M ; Hall, Timothy L ; Kieran, Kathleen ; Fowlkes, J. Brian ; Cain, Charles A ; Roberts, William W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c561t-4bffcc4c02c3a2006e206c631e457f11df2057bde46d66fe5b1983e06c9942193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Disease Models, Animal</topic><topic>Dogs</topic><topic>Equipment Design</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Prostate - metabolism</topic><topic>Prostate - pathology</topic><topic>Prostatic Hyperplasia - diagnosis</topic><topic>Prostatic Hyperplasia - therapy</topic><topic>Subcellular Fractions</topic><topic>Ultrasonic Therapy</topic><topic>Ultrasound, High-Intensity Focused, Transrectal - instrumentation</topic><topic>Ultrasound, High-Intensity Focused, Transrectal - methods</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lake, Alison M</creatorcontrib><creatorcontrib>Hall, Timothy L</creatorcontrib><creatorcontrib>Kieran, Kathleen</creatorcontrib><creatorcontrib>Fowlkes, J. Brian</creatorcontrib><creatorcontrib>Cain, Charles A</creatorcontrib><creatorcontrib>Roberts, William W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lake, Alison M</au><au>Hall, Timothy L</au><au>Kieran, Kathleen</au><au>Fowlkes, J. Brian</au><au>Cain, Charles A</au><au>Roberts, William W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><addtitle>Urology</addtitle><date>2008-09-01</date><risdate>2008</risdate><volume>72</volume><issue>3</issue><spage>682</spage><epage>686</epage><pages>682-686</pages><issn>0090-4295</issn><eissn>1527-9995</eissn><coden>URGYAZ</coden><abstract>Objectives Symptoms of benign prostatic hyperplasia affect men increasingly as they age. Minimally invasive therapies for the treatment of benign prostatic hyperplasia continue to evolve. We describe histotripsy, a noninvasive, nonthermal, focused ultrasound technology for precise tissue ablation, and report the initial results of using histotripsy for prostatic tissue ablation in an in vivo canine model. Methods An annular 18-element, 750-kHz, phased-array ultrasound system delivered high-intensity (22 kW/cm2 ), ultrasound pulses (15 cycles in 20 ms) at pulse repetition frequencies of 100 to 500 Hz to canine prostates. Eight lateral lobe and nine periurethral treatments were performed in 11 anesthetized dogs. Diagnostic ultrasound transducers provided in-line and transrectal imaging. Retrograde urethrography was performed before and after the periurethral treatments. After treatment, the prostates were grossly examined, sectioned, and submitted for histologic examination. Results In the lateral lobe treatments, a well-demarcated cavity containing liquefied material was present at the ablation site. Microscopically, the targeted volume was characterized by the presence of histotripsy paste (debris, absent cellular structures). A narrow margin of cellular injury was noted, beyond which no tissue damage was apparent. The periurethral treatments resulted in total urethral ablation or significant urethral wall damage, with visible prostatic urethral defects on retrograde urethrography. Real-time ultrasound imaging demonstrated a dynamic hyperechoic zone at the focus, indicative of cavitation and suggesting effective tissue ablation. Conclusions The results of our study have shown that histotripsy is capable of precise prostatic tissue destruction and results in subcellular fractionation of prostate parenchyma. Histotripsy can also produce prostatic urethral damage and thereby facilitate drainage of finely fractionated material per urethra, producing immediate debulking.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18342918</pmid><doi>10.1016/j.urology.2008.01.037</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2008-09, Vol.72 (3), p.682-686
issn 0090-4295
1527-9995
language eng
recordid cdi_proquest_miscellaneous_69492788
source MEDLINE; Elsevier ScienceDirect Journals
subjects Animals
Biological and medical sciences
Disease Models, Animal
Dogs
Equipment Design
Humans
Male
Medical sciences
Nephrology. Urinary tract diseases
Prostate - metabolism
Prostate - pathology
Prostatic Hyperplasia - diagnosis
Prostatic Hyperplasia - therapy
Subcellular Fractions
Ultrasonic Therapy
Ultrasound, High-Intensity Focused, Transrectal - instrumentation
Ultrasound, High-Intensity Focused, Transrectal - methods
Urology
title Histotripsy: Minimally Invasive Technology for Prostatic Tissue Ablation in an In Vivo Canine Model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T12%3A54%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Histotripsy:%20Minimally%20Invasive%20Technology%20for%20Prostatic%20Tissue%20Ablation%20in%20an%20In%20Vivo%20Canine%20Model&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Lake,%20Alison%20M&rft.date=2008-09-01&rft.volume=72&rft.issue=3&rft.spage=682&rft.epage=686&rft.pages=682-686&rft.issn=0090-4295&rft.eissn=1527-9995&rft.coden=URGYAZ&rft_id=info:doi/10.1016/j.urology.2008.01.037&rft_dat=%3Cproquest_cross%3E69492788%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69492788&rft_id=info:pmid/18342918&rft_els_id=S0090429508001064&rfr_iscdi=true